Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × Metformin × Gynecologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1 Gynecologic 1 CNS 1

Conditions

Endometrial Neoplasms 13 Ovarian Neoplasms 4 Carcinoma, Ovarian Epithelial 4 Breast Neoplasms 3 Uterine Cervical Neoplasms 2 Pancreatic Neoplasms 2 Lung Neoplasms 2 Kidney Neoplasms 2 Fallopian Tube Neoplasms 2 Endometrial Hyperplasia 2 Colonic Neoplasms 2 Waldenstrom Macroglobulinemia 1 Triple Negative Breast Neoplasms 1 Small Cell Lung Carcinoma 1 Sezary Syndrome 1 Recurrence 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pleural Effusion, Malignant 1 Ovarian, Fallopian Tube, and Primary Peritoneal Cancer 1 Neoplasms 1 Neoplasm Metastasis 1 Mycosis Fungoides 1 Melanoma 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1

Interventions

Paclitaxel 17 Carboplatin 17 Cisplatin 9 Cyclophosphamide 7 Bevacizumab 6 Topotecan 5 Gemcitabine 5 pembrolizumab 4 olaparib 4 Letrozole 4 Interleukin-2 4 Doxorubicin 4 rucaparib 3 liposomal doxorubicin 3 fludarabine 3 chiauranib 3 cemiplimab 3 camrelizumab 3 Injections 3 Hyperthermic Intraperitoneal Chemotherapy 3 Everolimus 3 Drug Therapy 3 Albumin-Bound Paclitaxel 3 pazopanib 2 iniparib 2 eprenetapopt 2 durvalumab 2 avelumab 2 apatinib 2 aldesleukin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03538704 2018-05-29

ECFerSp

Peking University People's Hospital

Phase NA Unknown

Recurrence, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡